Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech Announces Completion of Share Consolidation

MarketWire Canada March 10, 2017

Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra

Marketwired March 6, 2017

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

MarketWire Canada December 21, 2016

Kane Biotech Announces Results of Special Meeting and Proposed Share Consolidation

MarketWire Canada December 16, 2016

Kane Biotech Announces Shareholder Meeting to Consider Share Consolidation

MarketWire Canada November 25, 2016

Kane Biotech Launches New Branding for StrixNB Oral Health Products for Dogs and Cats

MarketWire Canada October 19, 2016

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

MarketWire Canada September 28, 2016

Kane Biotech Announces End of Joint Development Agreement and Appointment of Vice-President Sales

MarketWire Canada July 11, 2016

Kane Biotech Announces Closing of Private Placement Offering and Issuance of Common Shares in Payment of Outstanding Interest

MarketWire Canada June 29, 2016

Kane Biotech Announces Grant of Options

MarketWire Canada June 21, 2016

Kane Biotech Announces Board Members

MarketWire Canada June 6, 2016

Kane Biotech Announces Private Placement Offering and Proposed Consolidation of Shares

MarketWire Canada June 2, 2016

Kane Biotech Announces Insider Participation in Rights Offering

Marketwired May 4, 2016

Kane Biotech Announces bluestem(TM) Breakthrough Order with Major Retail Chain

Marketwired April 26, 2016

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

Marketwired April 7, 2016

Kane Biotech Announces Rights Offering

Marketwired March 29, 2016

Kane Biotech Expanding bluestem(TM) to the USA

Marketwired March 1, 2016

Kane Biotech Announces Private Placement Offering

Marketwired January 27, 2016

Kane Biotech Receives $240,000 From Warrant Exercise

Marketwired January 8, 2016

Kane Biotech Appoints New CFO and Announces Addition of Commercialization Team Resources, Sales Representation Agreement for U.S. Market Expansion, and Grant of Options

Marketwired January 5, 2016